Cardiol.2001;87(5):577–583.
130.AckermannK,BallingG,EickenA,etal.
Replacementofthesystemicatrioventricular
valvewithamechanicalprosthesisinchildren
agedlessthan6years:lateclinicalresultsof
survivalandsubsequentreplacement.JThorac
CardiovascSurg.2007;134(3):750–756.
131.KadobaK,JonasRA,MayerJE,CastanedaAR.
Mitralvalvereplacementinthefirstyearoflife.
JThoracCardiovascSurg.1990;100(5):762–
768.
132.WilliamsDB,DanielsonGK,McGoonDC,etal.
Porcineheterograftvalvereplacementin
children.JThoracCardiovascSurg.
1982;84(3):446–450.
133.ZwengTN,BluettMK,MoscaR,CallowLB,
BoveEL.Mitralvalvereplacementinthefirst5
yearsoflife.AnnThoracSurg.1989;47(5):720–
724.
134.BrownJW,RuzmetovM,RodefeldMD,
TurrentineMW.Mitralvalvereplacementwith
RossIItechnique:initialexperience.Ann
ThoracSurg.2006;81(2):502–507[discussion
507–508].
135.EmaniSM,PiekarskiBL,ZurakowskiD,etal.
Conceptofanexpandablecardiacvalvefor
surgicalimplantationininfantsandchildren.J
ThoracCardiovascSurg.2016;152(6):1514–
1523.
136.BrownJW,RuzmetovM,RodefeldMD,VijayP,
TurrentineMW.Rightventricularoutflowtract
reconstructionwithanallograftconduitinnonrosspatients:riskfactorsforallograft
dysfunctionandfailure.AnnThoracSurg.
2005;80(2):655–663[discussion663–664].
137.WellsWJ,ArroyoHJr,BremnerRM,WoodJ,
StarnesVA.Homograftconduitfailureininfants
isnotduetosomaticoutgrowth.JThorac
CardiovascSurg.2002;124(1):88–96.
138.TweddellJS,PelechAN,FrommeltPC,etal.
Factorsaffectinglongevityofhomograftvalves
usedinrightventricularoutflowtract
reconstructionforcongenitalheartdisease.
Circulation.2000;102(19suppl3):III130–
III135.
139.ChristensonJT,ValaD,SierraJ,BeghettiM,
KalangosA.Bloodgroupincompatibilityand
acceleratedhomograftfibrocalcifications.J
ThoracCardiovascSurg.2004;127(1):242–250.
140.BandoK,DanielsonGK,SchaffHV,etal.
Outcomeofpulmonaryandaortichomografts
forrightventricularoutflowtractreconstruction.
JThoracCardiovascSurg.1995;109(3):509–
517[discussion517–518].
141.HawkinsJA,BaileyWW,DillonT,Schwartz
DC.Midtermresultswithcryopreserved
allograftvalvedconduitsfromtherightventricle
tothepulmonaryarteries.JThoracCardiovasc
Surg.1992;104(4):910–916.
142.JashariR,DaenenW,MeynsB,VanderkelenA.
IsABOgroupincompatibilityreallythereason
ofacceleratedfailureofcryopreservedallografts
inveryyoungpatients?–Echographyassessment
oftheEuropeanHomograftBank(EHB)
cryopreservedallograftsusedforreconstruction
oftherightventricularoutflowtract.CellTissue
Bank.2004;5(4):253–259.
143.DignanR,O'BrienM,HoganP,etal.Influence
ofHLAmatchingandassociatedfactorson
aorticvalvehomograftfunction.JHeartValve
Dis.2000;9(4):504–511.
144.BaskettRJ,NantonMA,WarrenAE,RossDB.
Humanleukocyteantigen-DRandABO
mismatchareassociatedwithaccelerated
homograftvalvefailureinchildren:implications
fortherapeuticinterventions.JThorac
CardiovascSurg.2003;126(1):232–239.
145.PurohitM,KitchinerD,PozziM.Contegra
bovinejugularveinrightventricletopulmonary
arteryconduitinRossprocedure.AnnThorac
Surg.2004;77(5):1707–1710.